• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Correction: Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target.

作者信息

Abid Junaid, Al-Rawi Mahmood Basil A, Mahmood Ahmad, Li An, Jiang Tiemin

机构信息

State Key Laboratory of Food Nutrition and Safety, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300222, China.

Department of Optometry, College of Applied Medical Sciences, King Saud University, Riyadh, 11433, Saudi Arabia.

出版信息

Hereditas. 2025 Apr 25;162(1):69. doi: 10.1186/s41065-025-00433-4.

DOI:10.1186/s41065-025-00433-4
PMID:40281630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12032749/
Abstract
摘要

相似文献

1
Correction: Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target.更正:弥漫性大B细胞淋巴瘤关键生物标志物的鉴定与功能表征:着重介绍STYX作为一种预后标志物和治疗靶点。
Hereditas. 2025 Apr 25;162(1):69. doi: 10.1186/s41065-025-00433-4.
2
Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target.弥漫性大B细胞淋巴瘤关键生物标志物的鉴定与功能表征:重点关注STYX作为预后标志物和治疗靶点。
Hereditas. 2025 Mar 24;162(1):45. doi: 10.1186/s41065-025-00411-w.
3
Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤中5-甲基胞嘧啶相关基因的鉴定与验证
Heliyon. 2023 Nov 10;9(11):e22209. doi: 10.1016/j.heliyon.2023.e22209. eCollection 2023 Nov.
4
FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma.脂肪酸合酶(FASN)和脂肪酸转运蛋白36(CD36)可预测利妥昔单抗治疗的弥漫性大B细胞淋巴瘤患者的生存期。
J Hematop. 2013 Mar;6(1):11-18. doi: 10.1007/s12308-012-0166-4.
5
A novel cancer-associated fibroblast-related gene signature for predicting diffuse large B cell lymphoma prognosis using weighted gene co-expression network analysis and machine learning.一种利用加权基因共表达网络分析和机器学习预测弥漫性大B细胞淋巴瘤预后的新型癌症相关成纤维细胞相关基因特征。
J Int Med Res. 2025 Apr;53(4):3000605251331250. doi: 10.1177/03000605251331250. Epub 2025 Apr 25.
6
Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.225例初发弥漫性大B细胞淋巴瘤及276例其他B细胞淋巴瘤中异常T细胞标志物表达的临床及预后意义
Oncotarget. 2017 May 16;8(20):33487-33500. doi: 10.18632/oncotarget.16532.
7
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program.自动化定量免疫荧光分析显示 PD-1/PD-L1 的表达和相互作用对伴有 T 细胞浸润的弥漫性大 B 细胞淋巴瘤患者有不良预后影响:来自国际弥漫性大 B 细胞淋巴瘤合作项目的研究。
Mod Pathol. 2019 Jun;32(6):741-754. doi: 10.1038/s41379-018-0193-5. Epub 2019 Jan 21.
8
Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma.多组学研究弥漫性大 B 细胞淋巴瘤预后生物标志物的进展。
Int J Biol Sci. 2022 Jan 9;18(4):1313-1327. doi: 10.7150/ijbs.67892. eCollection 2022.
9
Pseudophosphatase STYX promotes tumor growth and metastasis by inhibiting FBXW7 function in colorectal cancer.假磷酸酶 STYX 通过抑制结直肠癌中 FBXW7 的功能促进肿瘤生长和转移。
Cancer Lett. 2019 Jul 10;454:53-65. doi: 10.1016/j.canlet.2019.04.014. Epub 2019 Apr 11.
10
Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.编码蛋白的B细胞分化基因在弥漫性大B细胞淋巴瘤和3级滤泡性淋巴瘤中的预后意义
Croat Med J. 2008 Oct;49(5):625-35. doi: 10.3325/cmj.2008.5.625.

本文引用的文献

1
Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target.弥漫性大B细胞淋巴瘤关键生物标志物的鉴定与功能表征:重点关注STYX作为预后标志物和治疗靶点。
Hereditas. 2025 Mar 24;162(1):45. doi: 10.1186/s41065-025-00411-w.